BIOTECHNOLOGY VALUE FUND L P - 11 Aug 2025 SCHEDULE 13G Report for Structure Therapeutics Inc. Ordinary Shares, par value $0.0001 per share (GPCR)

Filing Manager
BIOTECHNOLOGY VALUE FUND L P
Reporting Manager
BVF PARTNERS L P/IL
Security
Structure Therapeutics Inc. Ordinary Shares, par value $0.0001 per share
Symbol
GPCR
Shares outstanding
172M shares
Disclosed Ownership
9.61M shares
Ownership
5.6%
Form type
SCHEDULE 13G
Filing time
18 Aug 2025, 17:02:11 UTC
Date of event
11 Aug 2025
SEC
View on sec.gov

Reporting Managers (10)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
BIOTECHNOLOGY VALUE FUND L P 2.9% 4.99M 0 4.99M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF I GP LLC 2.9% 4.99M 0 4.99M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BIOTECHNOLOGY VALUE FUND II LP 2.3% 3.9M 0 3.9M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF II GP LLC 2.3% 3.9M 0 3.9M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
Biotechnology Value Trading Fund OS LP 0.3% 531K 0 531K /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF Partners OS Ltd. 0.3% 531K 0 531K /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF GP HOLDINGS LLC 5.1% 8.89M 0 8.89M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF PARTNERS L P/IL 5.6% 9.61M 0 9.61M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF INC/IL 5.6% 9.61M 0 9.61M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
LAMPERT MARK N 5.6% 9.61M 0 9.61M /s/ Mark N. Lampert Mark N. Lampert